Volume Spike Investor

We are seeing a rather large price reaction to the downside and a subsequent volume spike as a result of news from Altus Pharmaceuticals Inc. (NASDAQ: ALTU).  This stock is down sharply after mixed results in a cystic fibrosis Phase III trial in patients with pancreatic insufficiency.   The study met some of the endpoints, but [...]